Key Events This Week
30 Mar: Stock hits 52-week and all-time low at Rs.224.1 amid market downturn
1 Apr: Sharp rebound with 7.02% gain to Rs.244.05 as Sensex rallies
2 Apr: Marginal gain of 0.18% to Rs.244.50 on low volume
3 Apr: Week closes at Rs.244.50, up 4.85% vs Sensex down 0.29%
30 March 2026: Suraksha Diagnostic Hits 52-Week and All-Time Low Amid Market Weakness
On 30 March, Suraksha Diagnostic Ltd’s share price plunged to a fresh 52-week and all-time low of Rs.224.1, closing at Rs.228.05, down 2.21% on the day. This decline extended a three-day losing streak with a cumulative drop of 12.11%, reflecting significant bearish pressure. The stock underperformed its sector by 2.25% and traded below all key moving averages, signalling a sustained downtrend.
The broader market was also weak, with the Sensex falling 2.29% to 32,182.38, pressured by macroeconomic concerns. Suraksha’s deteriorating financial metrics contributed to the negative sentiment. The company’s operating profit to interest coverage ratio fell to 7.33 times, its lowest level, while the debt-to-equity ratio rose to 0.51 times, the highest recorded. Interest expenses increased to Rs.3.16 crore, indicating rising financial costs.
Despite these challenges, Suraksha maintains a low debt-to-EBITDA ratio of 0.87 times and a respectable ROCE of 15.8%, reflecting operational resilience. However, technical indicators such as MACD and Bollinger Bands signalled bearish momentum, reinforcing the downtrend.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- - Highest rated stock selection
- - Multi-parameter screening cleared
- - Large Cap quality pick
1 April 2026: Sharp Rebound as Market Recovers
Following the steep decline, Suraksha Diagnostic Ltd staged a strong recovery on 1 April, surging 7.02% to close at Rs.244.05. This rally outpaced the Sensex’s 1.97% gain, signalling renewed investor interest and a technical bounce from oversold levels. The volume on this day was moderate at 2,731 shares, indicating selective buying.
The rebound was supported by stabilising financial indicators and the broader market’s positive momentum. The stock’s recovery above the 5-day moving average suggested a potential short-term reversal, although longer-term moving averages remained overhead resistance. The company’s institutional holding of 36.03% may have provided some support amid the volatility.
2 April 2026: Consolidation on Low Volume
On 2 April, Suraksha Diagnostic Ltd’s stock price edged up marginally by 0.18% to Rs.244.50, on thin volume of 604 shares. This modest gain reflected a consolidation phase following the sharp rebound, with investors awaiting further cues. The Sensex also posted a slight gain of 0.08%, indicating a broadly stable market environment.
Technical indicators remained mixed, with the Relative Strength Index showing no clear directional bias. The stock remained below key resistance levels at Rs.258.70 (20-day moving average) and Rs.278.23 (100-day moving average), suggesting that further upside would require sustained buying interest.
Holding Suraksha Diagnostic Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Weekly Price Performance: Suraksha Diagnostic Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-03-30 | Rs.228.05 | -2.21% | 32,182.38 | -2.29% |
| 2026-04-01 | Rs.244.05 | +7.02% | 32,814.97 | +1.97% |
| 2026-04-02 | Rs.244.50 | +0.18% | 32,839.65 | +0.08% |
Key Takeaways
Suraksha Diagnostic Ltd’s week was characterised by a sharp recovery following a significant decline to an all-time low. The stock outperformed the Sensex by 5.14 percentage points, gaining 4.85% while the benchmark index fell 0.29%. This rebound was driven by improved market sentiment and stabilising financial metrics.
However, caution remains warranted given the company’s elevated debt levels, rising interest expenses, and bearish technical indicators. The stock continues to trade below key moving averages, and resistance levels remain intact. Institutional holdings remain strong at 36.03%, which may provide some support amid volatility.
Financially, Suraksha Diagnostic shows mixed signals: while operating profit growth is robust at an annualised 89.29%, and ROCE is a healthy 15.8%, the deteriorating interest coverage ratio and increased debt-to-equity ratio highlight ongoing financial pressures. The company’s valuation multiples remain moderate, with a P/E of 37x and EV/EBITDA of 14.57x.
Conclusion
Suraksha Diagnostic Ltd’s performance this week reflects a tentative recovery from a challenging period marked by a new all-time low. The stock’s 4.85% gain against a declining Sensex underscores resilience amid broader market weakness. Nonetheless, the company’s financial and technical indicators suggest that investors should monitor debt levels and price momentum closely in the near term. The coming weeks will be critical in determining whether this rebound can be sustained or if the downtrend will resume.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
